Last updated on April 23, 2014 at 10:37 EDT

Latest Sphingotec GmbH Stories

2013-01-02 12:22:26

HENNIGSDORF, Germany, Jan. 2, 2013 /PRNewswire/ -- Sphingotec GmbH announced today that it will launch a blood test for the early prediction of breast cancer in women. The test will be available in Europe beginning in the second quarter of 2013. sphingotest(®) pro-NT is a simple blood test for the determination of proneurotensin (pro-NT). sphingotest(® )pro-NT detects the release of the satiety hormone neurotensin and is applicable to all female individuals, regardless of genetic...